Private Capital Group, LLC Bluebird Bio, Inc. Transaction History
Private Capital Group, LLC
- $133 Million
- Q2 2022
A detailed history of Private Capital Group, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 246 shares of BLUE stock, worth $2,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
246Holding current value
$2,137% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding BLUE
# of Institutions
150Shares Held
63.4MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$134 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$40.7 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$40.6 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$33.4 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $670M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...